Navigation Links
BioMS Medical to present at BioContact 2007
Date:9/28/2007

Toronto Stock Exchange Symbol: MS

EDMONTON, Sept. 28 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Tony Hesby, Executive Vice President Corporate Affairs, will give a corporate presentation at BioContact 2007 in Quebec City.

WHEN: Wednesday 3rd October, 2007 at 2:30pm (EST)

WHERE: Chateau Frontenac, Quebec

About BioMS Medical Corp.

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. For further information please visit our website at http://www.biomsmedical.com.

This news release may contain certain forward-looking statements that reflect the current views and/or expectations of BioMS Medical with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly.


'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Barriers will not stop convergence of medical technologies
3. Medical College team creates website for tracking flu
4. Biomedical engineering conference invites manufacturers
5. Visions: Wade offers straight talk on e-medical records
6. Merge unveils updated medical imaging software
7. Medical College receives $1.4M cancer grant
8. Medical technology firm lands $100K federal grant
9. Doyle outlines spending for Medical College, UWM
10. And the winners in medical design are
11. Manufacturing partnership will move into biotech and biomedical spaces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... and TEL AVIV, Israel , May ... the "Company") (NYSE MKT: NSPR), a leader in embolic protection ... Company,s President and Chief Executive Officer, and Craig ... in the Benchmark Company, LLC One-on-One Investor Conference on Thursday ... Ave., Milwaukee, WI. The ...
(Date:5/24/2013)... 24, 2013 Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel flavor ... , Ph.D., the Company,s Vice President, Biology and ... & Corporate Communications, will present an overview of Senomyx,s ... a.m. Eastern Time (7:25 a.m. Pacific Time) during the ...
(Date:5/24/2013)... 2013 This market report summarizes ... profiling carried out in May 2013. The full ... of the responses for each question, its segmentation ... also highlights some interesting differences, particularly between Pharma, ... models were developed to estimate the in house ...
(Date:5/24/2013)... 24, 2013 Many factors impact tissues ... or efflux transporters at the blood-tissue barrier. Even when ... unbound fractions in the tissue rather than the total ... challenges is required to guide lead optimization, predict in ... species-dependent variables that may impact the likely human clinical ...
Breaking Biology Technology:InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2
... Md., Sept. 24 PharmAthene, Inc.,(Amex: ... the development and,commercialization of medical countermeasures against ... of Health and Human,Services has published an ... the,amount of $13,920,347, listing PharmAthene as the ...
... and OXFORD, England, September 24, Evotec AG (Frankfurt Stock ... and Dr John Kemp, Chief,Research & Development Officer, will ... 03.30 pm EST (09.30 pm CET/08.30 pm BST) on,Wednesday, ... During the,presentation management will provide an overview of its ...
... leading,provider of quality research reagents for monitoring the immune ... of its new,MHC-peptide binding assay for Class II HLA ... I HLA already available from the Company. The ... is a,powerful cell-free in vitro assay that can rapidly ...
Cached Biology Technology:Evotec to Present at the UBS 2007 Global Life Sciences Conference in New York 2ProImmune Launches New MHC-Peptide Binding Assay for Class II HLA Alleles 2
(Date:5/24/2013)... system to combat metastatic cancer , Cancer cells ... the immune system. Stimulation of the immune system can ... factors that cause the immune system to ignore cancer ... to suppress the immune system response. In this issue ... led by Ronald Levy at Stanford University found that ...
(Date:5/24/2013)... detection and destruction by the immune system. Stimulation of ... however, there are many factors that cause the immune ... immune cells that function to suppress the immune system ... Clinical Investigation , researchers led by Ronald Levy at ... tumors express proteins that can be targeted with therapeutic ...
(Date:5/24/2013)... recent years, microRNAs (miRNAs) and other non-coding RNAs ... of specific proteins. In recent years they have ... used to establish tissue origin for cancers of ... and screen for disease, but clinically tractable, diagnostic ... are not currently available. In this issue of ...
Breaking Biology News(10 mins):JCI early table of contents for May 24, 2013 2JCI early table of contents for May 24, 2013 3JCI early table of contents for May 24, 2013 4JCI early table of contents for May 24, 2013 5JCI early table of contents for May 24, 2013 6JCI early table of contents for May 24, 2013 7JCI early table of contents for May 24, 2013 8
... 2012 Commonly prescribed anti-depressants appear to be doing patients ... paper examining the impact of the medications on the entire ... widespread use of these drugs," says Paul Andrews, an evolutionary ... published today in the online journal Frontiers in Psychology ...
... to the antidepressant Zoloft in yeast cells that could ... about how antidepressants work, as well as support the ... neurotransmitter serotonin. In findings published in the journal ... of Ethan Perlstein, an associate research scholar in Princeton,s ...
... the analysis of flavanols in cocoa has been developed ... scientific division of Mars, Incorporated, and recently published in ... the research team,s expertise in flavanol chemistry and analytics, ... of flavanols found in cocoa and chocolate products. Foods ...
Cached Biology News:Evidence shows that anti-depressants likely do more harm than good, researchers find 2Yeast cell reaction to Zoloft suggests alternative cause, drug target for depression 2Yeast cell reaction to Zoloft suggests alternative cause, drug target for depression 3Yeast cell reaction to Zoloft suggests alternative cause, drug target for depression 4Scientists advance field of research with publication of newly validated method for analyzing flavanols in cocoa 2
Rabbit polyclonal to Factor IX ( Abpromise for all tested applications). entrezGeneID: 2158 SwissProtID: P00740...
Adhesion Molecule Antibodies...
Rabbit polyclonal to Glutathione S Transferase alpha ( Abpromise for all tested applications). Antigen: Full length protein: Human Glutathione S Transferase alpha. Entrez GeneID: 2938 Swi...
Polyclonal antiserum raised against conjugated L-isoleucine. Available as antiserum. Amino Acid Antibodies...
Biology Products: